Outcomes | |
Follow-up (months) (median (range)) | 33.4 (2.6–112) |
OS (months) (median (95% CI)) | 32.7 (16.3 to 49.1) |
DFS (months) (median (95% CI)) | 23 (4.4 to 41.6) |
Prognosis | 22 deaths, 21 relapses |
OS (%) | |
OS at 3 years | 49.8 |
OS at 5 years | 31.1 |
DFS (%) | |
DFS at 3 years | 42.7 |
DFS at 5 years | 16 |
DFS, disease free survival; OS, overall survival.